PPARγ signaling: One size fits all?

Cell Cycle

Volumn 3, Issue 11, 2004, Pages 1352-1354

  Jain, Anjali ^a   Agus, David B ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cancer; HER signaling network; Ligands; PPAR signaling

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRASTUZUMAB; ANTINEOPLASTIC AGENT; LIGAND;

ANTINEOPLASTIC ACTIVITY; AUTOPHOSPHORYLATION; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL DIFFERENTIATION; CELL MATURATION; DIMERIZATION; ENZYME ACTIVATION; GENE CONTROL; GENETIC PREDISPOSITION; HOMEOSTASIS; HUMAN; NONHUMAN; PROTEIN BINDING; PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TARGET CELL; TRANSACTIVATION; ANIMAL; ARTICLE; CELL PROLIFERATION; CHEMISTRY; COLORECTAL TUMOR; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; HUMANS; LIGANDS; PPAR GAMMA; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 14644430278     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.3.11.1210     Document Type: Short Survey

References (26)

1. Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med 2004; 10:355-61.
2. Na HK, Surh YJ. Peroxisome proliferator-activated receptor gamma (PPARγ) ligands as bifunctional regulators of cell proliferation. Biochem Pharmacol 2003; 66:1381-91.
3. Hedvat M, Jain A, Carson DA, Leoni LM, Huang G, Holden S, Lu D, Corr M, Fox W, Agus DB. Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARγ. Cancer Cell 2004; 5:565-74.
4. Grommes C, Landreth GE, Heneka MT. Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol 2004; 5:419-29.
5. Sarraf P, Mueller E, Jones D, King FJ, DeAngelo DJ, Partridge JB, Holden SA, Chen LB, Singer S, Fletcher C, Spiegelman BM. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat Med 1998; 4:1046-52.
6. Saez E, Tontonoz P, Nelson MC, Alvarez JG, Ming UT, Baird SM, Thomazy VA, Evans RM. Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat Med 1998; 4:1058-61.
7. Lefebvre AM, Chen I, Desreumaux P, Najib J, Fruchart JC, Geboes K, Briggs M, Heyman R, Auwerx J. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 1998; 4:1053-7.
8. Saez E, Rosenfeld J, Livolsi A, Olson P, Lombardo E, Nelson M, Banayo E, Cardiff RD, Izpisua-Belmonte JC, Evans RM. PPAR gamma signaling exacerbates mammary gland tumor development. Genes Dev 2004; 18:528-40.
9. Saez E, Olson P, Evans RM. Genetic deficiency in PPARγ does not alter development of experimental prostate cancer. Nat Med 2003; 9:1265-6.
10. Back SJ, Wilson LC, Hsi LC, Eling TE. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPARγ) ligand, selectively induces the early growth response-1 gene independently of PPARγ. A novel mechanism for its anti-tumorigenic activity. J Biol Chem 2003; 278:5845-53.
11. Juge-Aubry CE, Hammar E, Siegrist-Kaiser C, Pernin A, Takeshita A, Chin WW, Burger AG, Meier CA. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain. J Biol Chem 1999; 274:10505-10.
12. Hu E, Kim JB, Sarraf P, Spiegelman BM. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 1996; 274:2100-3.
13. Camp HS, Tafuri SR, Leff T. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γl and negatively regulates its transcriptional activity. Endocrinology 1999; 140:392-7.
14. Camp HS, Whitton AL, Tafuri SR. PPARγ activators down-regulate the expression of PPARγ in 3T3-L1 adipocytes. FEBS Lett 1999; 447:186-90.
15. Teruel T, Hernandez R, Benito M, Lorenzo M. Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes. J Biol Chem 2003; 278:263-9.
16. Rokos CL, Ledwith BJ. Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells. J Biol Chem 1997; 272:13452-7.
17. Mounho BJ, Thrall BD. The extracellular signal-regulated kinase pathway contributes to mitogenic and antiapoptotic effects of peroxisome proliferators in vitro. Toxicol Appl Pharmacol 1999; 159:125-33.
18. Lennon AM, Ramauge M, Dessouroux A, Pierre M. MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. J Biol Chem 2002; 277:29681-5.
19. Marmor MD, Skaria KB, Yarden Y. Signal transduction and oncogenesis by ErbB/HER receptors. Int J Radiat Oncol Biol Phys 2004; 58:903-13.
20. Gross ME, Shazer RL, Agus DB. Targeting the HER-kinase axis in cancer. Semin Oncol 2004; 31:9-20.
21. Arteaga CL. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia. Semin Oncol 2002; 29:3-9.
22. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2:127-37.
23. Gardner OS, Dewar BJ, Earp HS, Samet JM, Graves LM. Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation. J Biol Chem 2003; 278:46261-9.
24. Yang Z, Bagheri-Yarmand R, Balasenthil S, Hortobagyi G, Sahin AA, Bames CJ, Kumar R. HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARγ) expression and sensitivity of breast cancer cells to PPARγ ligand therapy. Clin Cancer Res 2003; 9:3198-203.
25. Pignatelli M, Cortes-Canteli M, Lai C, Santos A, Perez-Castillo A. The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. J Cell Sci 2001; 114:4117-26.
26. Siavash H, Nikitakis NG, Sauk JJ. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells. Cancer Lett 2004; 211:97-103.